Does LINAGLIPTIN Cause Malignant neoplasm progression? 8 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 8 reports of Malignant neoplasm progression have been filed in association with LINAGLIPTIN (Linagliptin and metformin hydrochloride). This represents 0.1% of all adverse event reports for LINAGLIPTIN.
8
Reports of Malignant neoplasm progression with LINAGLIPTIN
0.1%
of all LINAGLIPTIN reports
4
Deaths
4
Hospitalizations
How Dangerous Is Malignant neoplasm progression From LINAGLIPTIN?
Of the 8 reports, 4 (50.0%) resulted in death, 4 (50.0%) required hospitalization.
Is Malignant neoplasm progression Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for LINAGLIPTIN. However, 8 reports have been filed with the FAERS database.
What Other Side Effects Does LINAGLIPTIN Cause?
Blood glucose increased (804)
Dyspnoea (571)
Dizziness (529)
Pruritus (527)
Nausea (525)
Diarrhoea (509)
Vomiting (465)
Fatigue (464)
Malaise (457)
Arthralgia (446)
What Other Drugs Cause Malignant neoplasm progression?
PEMBROLIZUMAB (10,111)
NIVOLUMAB (9,363)
ENZALUTAMIDE (4,696)
CARBOPLATIN (4,177)
EVEROLIMUS (3,789)
PACLITAXEL (3,484)
LETROZOLE (3,445)
IPILIMUMAB (3,296)
FULVESTRANT (3,221)
LENVATINIB (2,929)
Which LINAGLIPTIN Alternatives Have Lower Malignant neoplasm progression Risk?
LINAGLIPTIN vs LINAGLIPTIN\METFORMIN
LINAGLIPTIN vs LINCOMYCIN
LINAGLIPTIN vs LINEZOLID
LINAGLIPTIN vs LINZESS
LINAGLIPTIN vs LIORESAL